Qiagen, NL0012169213

Qiagen stock heads into the open after a 1.1 percent gain

Published on 09/14/2026 at 07:47 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
At the close on September 11, 2026, Qiagen stock stood at USD 42.39 on its primary listing, up 1.1 percent for the day. The move came as investors digested an UBS upgrade and index inclusion news alongside solid trading volume.
Qiagen N.V. (NL0012169213) Pipette tropft klare Flüssigkeit in sterile 96-Well-Platte im klinischen Labor, Illustration mit AI erstellt.

Qiagen stock closed at USD 42.39 on September 11, 2026 on its primary listing, marking a 1.1% gain for the session. Per recent data, this level came with a market capitalization of about USD 8.74 billion and trading volume of roughly 1.11 million shares on that date.

September 11, 2026 in numbers

Qiagen N.V. (ISIN NL0012169213) ended the September 11, 2026 session at USD 42.39, up 1.1% from its prior close, with around 1.11 million shares changing hands. According to an overview cited in a corporate-news wrap, the price on September 11, 2026 translated into a market capitalization near USD 8.74 billion and reflected steady liquidity during the session.Ad-hoc-news reported that the advance came as Qiagen shares reacted to an analyst upgrade by UBS and inclusion in an ECPI index, giving the stock a modest tailwind in the latest session.

Today's outlook for September 14, 2026

Heading into today's session on September 14, 2026, Qiagen faces no major company-specific events flagged for this date in the latest investor-relations and market commentary. Recent coverage of the stock has focused on portfolio adjustments by institutional investors and the impact of the recent UBS rating action, suggesting that analysts will continue to watch how the shares trade around the USD 42 mark after the upgrade.MarketBeat noted ongoing institutional positioning in Qiagen, which can influence trading dynamics today even without a scheduled earnings release or corporate event.

Disclaimer...
en | NL0012169213 | QIAGEN | boerse | 70097171 | bgmi